Accumulating case reports have described tendon rupture in men using anabolic-androgenic steroids (AAS). However no controlled study, to our knowledge, has assessed history of tendon rupture in a large cohort of AAS users and comparison nonusers.
We hypothesized that men reporting long-term AAS abuse would report an elevated lifetime incidence of tendon rupture as compared to non-AAS-using bodybuilders.
We obtained medical histories from 142 experienced male bodybuilders age 35–55, recruited in the course of two studies. Of these men, 88 reported at least two years of cumulative lifetime AAS use and 54 reported no history of AAS use. In men reporting a history of tendon rupture, we recorded circumstances of the injury, prodromal symptoms, concomitant drug or alcohol use, and details of current and lifetime AAS use if applicable. We also obtained surgical records for most participants.
Nineteen (22%) of the AAS users, but only 3 (6%) of the nonusers reported at least one lifetime tendon rupture. The hazard ratio (95% confidence interval) for a first ruptured tendon in AAS users versus nonusers was 9.0 (2.5, 32.3); P <.001. Several men reported two or more independent lifetime tendon ruptures. Interestingly, upper body tendon ruptures occurred exclusively in the AAS group (15 [17%] of the AAS users versus 0 non-users; risk difference 0.17 (0.09, 0.25); P < 0.001 [hazard ratio not estimable]), whereas we found no significant difference between users and nonusers in risk for lower body ruptures (6 [7%] AAS users, 3 [6%] nonusers; hazard ratio 3.1 (0.7, 13.8), P = 0.13). Of 31 individual tendon ruptures that we assessed, only 6 (19%) occurred while weightlifting, with the majority occurring during other sports activities. Eight (26%) ruptures followed prodromal symptoms of nonspecific pain in the region. Virtually all ruptures were treated surgically with complete or near-complete ultimate restoration of function.